Jim Tananbaum serves as the Chief Executive Officer and founder of Foresite Capital. In 2011, Jim founded Foresite Capital, a healthcare privately held equity firm that specializes in identifying healthcare leaders that are emerging in the industry. As a result, the company invests in companies with late-stage and disruptive products and services in all the healthcare sectors such as genomics, diagnostics, biotechnology, medical devices and health services.
Foresite Capital is headquartered in San Francisco and has an additional office in New York. This healthcare firm invests in the leading innovative healthcare companies and is currently valued at approximately 1.1 billion dollars asset wise. The company offers emerging health care providers’ growth capital in the public and private sectors. Intarcia Therapeutics happens to be the current and largest investment of Foresite Capital. Intarcia is a type II diabetes implant aimed at helping patients control their weights and diabetes. According to Jim, the Intarcia product will help millions of diabetes patients around the world. Apart from Intarcia, Jim has undertaken another major investment in the health sector known as Juno Therapeutics. Visit LinkedIn to know more.
About Jim Tananbaum
Jim obtained an M.B.A from Harvard Business School and M.D Harvard Medical School. Jim also obtained a B.S.E.E and B.S. from Yale University as well as an M.S from MIT(Massachusetts Institute of Technology). Tananbaum has also served on the visiting committees and advisory boards of Yale School of Engineering and Harvard-MIT HST program. Jim has also been a founding partner at Prospect Venture Partners II and III as well as Sierra Ventures. Jim Tananbaum also held management positions at Theravance and GelTex Pharmaceuticals; companies acquired for 1.6 billion dollars by Genzyme.
Jim has over 25years of experience in the healthcare industry and has been mentored by some collaborators such as Rick Levin(Yale), George Whitesides (Harvard), Rick Klausner (NCI). Jim continues to collaborate with these leading entrepreneurs and academicians to get new insights in the health care sector. Some of Jim’s major successful investments consisted of Healtheon, Amerigroup, Amir and Jazz Pharmaceuticals. For the past three years, Jim has featured on the Midas List which has the top hundred investors. Visit officialjimtananbaum.com